BPC‑157 is a Healing and Repair  peptide designed to support your body’s own repair processes. It’s often chosen by people who want extra help looking after their gut, joints and soft tissues when life gets busy, training loads are high, or they are recovering from physical stress and injury.

This injectable formula delivers BPC‑157 directly into the circulation for targeted support, and is used under the guidance of a healthcare professional as part of a broader plan that can include nutrition, movement and lifestyle changes.

BPC‑157 is not an FDA‑approved medicine and is not intended to diagnose, treat, cure or prevent any disease. Always follow the advice of your prescribing practitioner.

Gut comfort & resilience
Helping to look after the stomach and digestive lining, especially during times of higher stress or when the gut feels more sensitive than usual.

Joint & tendon comfort
Extra support for areas that take a lot of load, such as knees, shoulders, elbows and ankles to help you feel more comfortable in everyday movement.

Recovery from physical stress
Back‑up for the body when you’re training hard, returning to activity, or simply asking more from your muscles and soft tissues.

Everyday mobility & performance
Supporting the tissues that help you move well so you can stay active, do the things you love, and bounce back more easily.

*Individual results will vary. Best used as part of a complete plan designed by your healthcare provider.

Presentation

5mL multidose vial (total peptide content 10,000mcg at 2,000mcg/mL)

Excipients

Sterile diluent (e.g., bacteriostatic saline) and standard compounding excipients as specified by the partner pharmacy (may include buffering agents and preservatives).

Protocol & Standard Dosing

Subcutaneous injection into fatty tissue (e.g., lower abdomen, outer thigh), using an insulin type syringe, as instructed by a healthcare professional.

Standard Dose (Maintenance / Symptom Support)

• 0.10 – 0.20mL subcutaneous (SC) injection daily before bed.
• 0.10mL ≈ 200mcg
• 0.20mL ≈ 400mcg

Administration Method:

Subcutaneous (SC) injection using an insulin syringe into fatty tissue (e.g., lower abdomen or outer thigh), as instructed by a healthcare professional.

Regenerative / Intensive Protocol

0.10mL SC in the morning and 0.10mL SC in the evening, daily.

Total daily dose ≈ 0.20mL (≈ 400mcg)

Listed as a prohibited substance in sport (World Anti‑Doping Code); athletes subject to testing should not use this product

Side Effects, Reactions & Medical Contraindications

Contraindications – Use is generally not recommended in:

• Known allergy or hypersensitivity to BPC‑157 or any component of the vial
• Pregnancy or breastfeeding (no adequate safety data)
• Active malignancy or history of cancer unless cleared by a specialist, due to theoretical concerns around angiogenesis and cell‑growth modulation 
• Severe uncontrolled cardiovascular, renal, hepatic, or autoimmune disease without specialist supervision
• Competitive/regulated athletes subject to WADA or similar anti‑doping rules

Common Side Effects and Adverse Reactions

• Local injection‑site reactions: redness, swelling, itching, bruising, pain
• Headache, dizziness or light‑headedness
• Nausea, stomach discomfort, diarrhea or constipation
• Fatigue, changes in energy or sleep disturbance
• Flushing or warmth sensations
• Because products are often unregulated, contamination or incorrect dosing may also contribute to side effects

Reactions Requiring Medical Attention

• Patients should stop injections and seek urgent medical care (or emergency services, if severe) if they experience:
• Signs of a serious allergic reaction: widespread rash, hives, facial/tongue swelling, difficulty breathing
• Chest pain, severe shortness of breath or rapid heartbeat
• Severe or persistent abdominal pain, vomiting or bloody stools
• Sudden, unexplained swelling, rapid weight gain, or marked changes in blood pressure
• Any other new or worsening symptoms that feel serious or concerning

Safety Note: Long‑term data is limited. Use should always be monitored by a qualified clinician, with regular reviews and ongoing medical supervision.  Informed consent is essential.